Home News Coronavirus Vaccine: Bharat Biotech Receives Approval; to Start Phase 3 Trials Next Month

Coronavirus Vaccine: Bharat Biotech Receives Approval; to Start Phase 3 Trials Next Month

Coronavirus Vaccine: Bharat Biotech Receives Approval; to Start Phase 3 Trials Next Month

Bharat Biotech that is developing its own coronavirus vaccine has received the drug regulatory authority’s approval for the initiation of the final phase of trials. Phase 3 of the trials is likely to start next month. The expert committee that met on Tuesday to approve Bharat Biotech’s third phase of trials gave the nod to the pharma company and suggested “minor amendments” in the protocol.

As many as 28,500 people are expected to enroll for the trials in India, as mentioned in a report in The Economic Times. The volunteers would be given two doses of the experimental vaccine in a gap of 28 days.

Savita Verma, principal investigator at PGI Rohtak told the daily that there were minor adverse reactions in some but overall the preliminary results showed that Covaxin is safe. The vaccine is the first of a long list of coronavirus vaccine candidates developed indigenously. Bharat Biotech developed the vaccine in collaboration with the Indian Council of Medical Research (ICMR).

As per earlier reports, the homegrown company has already written to states including asking them for permission to initiate trials. The firm in its application said that the study would cover 28,500 subjects aged 18 years and above and would be conducted in 19 sites — including Delhi, Mumbai, Patna, and Lucknow — across 10 states. The expert committee on October 5 had asked the company to resubmit its clinical trial proposal. The committee asked the company to clarify the definition of asymptomatic.

It also asked Bharat Biotech to submit full data of the Phase 2 trials. “However, the study should be initiated with an appropriate dose identified from the phase-2 safety and immunogenicity data. Accordingly, the firm should submit safety and immunogenicity data from the phase-2 trial for consideration,” the panel said in its recommendations.

Meanwhile, Bharat Biotech and Serum Institute are soon expected to start trials of an intranasal coronavirus vaccine, as mentioned by Health Minister Dr Harsh Vardhan.

Eskalera, a Startup Led by Goldman Sachs’ Former HR Head Has Launched a Diversity and Inclusion Index

Eskalera, a technology startup led by Goldman Sachs former human resources head Dane Holmes, has launched an index to measure corporate diversity and inclusiveness,...

HSBC to Remove 35,000 Jobs Amidst Covid-19 Crises

HSBC Holdings Plc has restarted cutting as many as 35,000 jobs, three months after the coronavirus outbreak forced it to pause a long-awaited overhaul...

Genpact Offers Its Internal Skill Training Program Globally for Everyone

Genpact has announced Adapt and Rise, a role-based online learning platform that leverages Genpact's expertise honed from delivering real-world change for hundreds of clients....

San-Francisco Based Learning Platform Degreed Has Raised $32 Million in New Funding

The upskilling platform, Degreed, has announced $32 million in new funding in direct response to overwhelming demand for better skill insights, talent mobility, and...

Research Shows the Implications of Workplace Layouts on Employee Productivity and Overall Performance

As some workplaces prepare for the gradual return of employees and overhaul office layouts and seating plans, research has shown this could also have...

Employee Concierge ‘Back Technologies’ Integrates Automation Into Internal HR and Other Support Tasks

Companies are under increasing pressure to automate workflows and digitally service their employees, particularly in light of trends toward remote work. It takes an...

HR Strategies to Help Your Business Navigate the New ‘Normal’

No business is immune to the massive changes resulting from the health crisis. Organizations have proven themselves to be agile, and employees have demonstrated...

The Importance Of Diversity And Inclusion In HR, Hiring, Talent Management: Thoughts From A Top Expert

Michael C. Hyter is one of today’s best-known experts on inclusion and diversity and the author of The Power of Choice: Embracing Efficacy to Drive Your Career and The...

HR Expert Highlights Actionable Steps to ‘Make Real Change’ Against Racism in Your Workplace

Kyra Leigh Sutton, Ph.D., is a faculty member at the Rutgers University School of Management and Labor Relations, where she teaches human resources courses...

Adidas Employees Want Company to Investigate HR Chief for Response to Racial Issues

A group of Adidas employees from around the globe is asking the company to investigate its chief human resources officer, as part of a...